Levacetylleucine (Aqneursa) improved neurologic symptoms and functioning in adults and children with ataxia-telangiectasia in ...
Only successful pivotal Phase III trial in Ataxia-Telangiectasia (A-T), a rare, progressive neurodegenerative disease with no approved treatments Phase III trial successfully achieved its primary ...
Scientists discovered that a key brain signal may have been pointing researchers in the wrong direction, potentially changing ...
Many neurological diseases damage specific parts of the brain, even though the harmful protein involved is present throughout the brain.
Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, today ...
Joubert syndrome (JS) is a rare ciliopathy characterised by the molar tooth sign on brain MRI, cerebellar vermis hypoplasia, hypotonia and developmental delay. We report an elementary school-aged boy ...
Scientists may have discovered a new role for the cerebellum, the part of the brain that sits at the base of the skull. A new paper published in the journal Nature Neuroscience reports that different ...
A new generation of therapies aims to intervene at a recently discovered gap between the disease’s molecular march and its ...
The cerebellum, the wizened “little brain” nestled in the base of the skull, may help keep us sharp as we age. Regions at the back of the cerebellum that resisted shrinkage with age were tied to ...
Celebrate World Chocolate Day by exploring chocolate's history, health benefits, and the latest 2026 research on cocoa flavanols and heart health.
While Alzheimer’s disease has no cure, treatments can help manage symptoms. Medications, experimental approaches, and off-label drugs may help manage memory loss. Cognitive behavioral therapy (CBT), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results